Case-Control Viramune (Nevirapine) Toxicogenomics Study

Mise à jour : Il y a 4 ans
Référence : NCT00310843

Femme et Homme

Extrait

Attempt to identify genetic polymorphisms in interrogated pathways which may be associated with symptomatic hepatotoxicity or severe cutaneous toxicity observed in case patients within the first 8 weeks of nevirapine therapy.


Critère d'inclusion

  • HIV Infections


Liens